The present invention relates to salts of organic acid, in particular salt
of nateglinide, combined preparations comprising one or more salts of
nateglinide and, optionally, one or more additional ingredients and the
use thereof in pharmaceutical compositions for preventing or treating
diabetes, cardiovascular diseases, or conditions associated therewith.
